Photo of David Huberman

David Huberman

David Huberman works closely with Israeli and domestic clients, representing issuers and underwriters on capital raising transactions, including private and public offerings. He regularly represents Israeli companies in their initial public offerings on U.S. stock exchanges and advises on ongoing compliance with U.S. securities laws. David’s clients include pharmaceutical and technology companies currently traded, or on their way to the Nasdaq.

Follow:Read more about David HubermanDavid's Linkedin Profile

On March 3, 2025, the SEC’s Division of Corporation Finance issued new guidance expanding the availability of confidential review of draft registration statements (DRS). Originally, DRS was for foreign private issuers and later extended to emerging growth companies (EGCs) under the JOBS Act in 2012. In 2017, the SEC allowed all companies to use DRS for IPOs and initial listings. The 2025 guidance removes the “initial filing” limitation, allowing both private and public companies to submit DRS for confidential review.
Continue Reading SEC Expands Confidential Review Process for Draft Registration Statements